1,084 results on '"Geisbert, Thomas W."'
Search Results
202. Towards a vaccine against Ebola virus
203. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
204. Preliminary report: isolation of Ebola virus from monkeys imported to USA
205. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys
206. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
207. A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge
208. Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization
209. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
210. Pathogenesis of lassa fever in cynomolgus macaques
211. Interferon-[beta] 1a and SARS coronavirus replication
212. The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
213. Colaboradores
214. 164 - Fiebres hemorrágicas por los virus Marburg y Ébola
215. Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
216. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
217. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
218. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.
219. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.
220. Small animal models of filovirus disease: recent advances and future directions
221. Two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates
222. Predicting outcome and improving treatment for Lassa fever
223. Erratum: Post-exposure treatments for Ebola and Marburg virus infections
224. Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
225. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
226. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
227. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge
228. Post-exposure treatments for Ebola and Marburg virus infections
229. Ebola Virus: The Role of Macrophages and Dendritic Cells in the Pathogenesis of Ebola Hemorrhagic Fever
230. siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease
231. Treatment of Ebola Virus Infection With a Recombinant Inhibitor of Factor Vlla/Tissue Factor: A Study in Rhesus Monkeys
232. Pathogenesis of Ebola Hemorrhagic Fever in Primate Models In Vivo and In Vitro
233. Towards a Vaccine Against Ebola Virus
234. Filovirus Pathogenesis in Nonhuman Primates
235. Contributors
236. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
237. Establishment of an African green monkey model for COVID-19 and protection against re-infection
238. 166 - Marburg and Ebola Hemorrhagic Fevers (Marburg and Ebola Viral Diseases) (Filoviruses)
239. Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
240. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
241. Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
242. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop
243. Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses
244. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody
245. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo
246. First Ebola virus vaccine to protect human beings?
247. The Gap Between Animal and Human Ebola Virus Disease
248. Persistence of Ebola virus RNA in seminal fluid
249. Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses
250. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.